National Coverage Analysis (NCA)

Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease

CAG-00431N

Expand All | Collapse All

Contacts

David Dolan
David.Dolan@cms.hhs.gov
410-786-3365
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
Original Consideration Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease CAG-00431N You are here
First reconsideration Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease CAG-00431R View